Plenty of self-care shoppers know exactly what they want and type the brand name. Those are the ones you have already won. The commercially interesting search is the other one, where somebody describes a problem and the retailer's search engine decides which products answer it. Your listing was built from the marketing authorisation and checked by regulatory affairs. Is it equipped for that conversation?
In short: A large share of self-care search is symptom-led or ingredient-led rather than brand-led, while OTC and supplement listings are usually built from regulatory copy. What a brand may claim is tightly constrained, but the structure of a listing is not, and attributes, format, ingredient naming and permitted supporting content all decide whether a product appears in symptom-led search and survives retailer filters. With online sales projected to account for around a quarter of OTC revenue, that gap is commercially material. This is the commercial companion to our pillar guide on digital shelf analytics for pharmaceutical and healthcare brands, which covers regulatory complexity, content accuracy and multi-market compliance in full.
Table of Contents
- Why does symptom-led search leave OTC listings behind?
- What are you actually allowed to say?
- Where does the real content opportunity sit?
- How do retailer filters decide what gets found?
- Where does prevention change the picture?
- What this means for your digital shelf strategy
Why does symptom-led search leave OTC listings behind?
In a pharmacy, the shopper describes the problem and the pharmacist translates it into a product. Online, the shopper types the problem into a search box and the retailer's search engine does the translating, working only with what is on your page.
The larger European online pharmacies understand this. Shop Apotheke prompts shoppers to search by symptom as well as by product or manufacturer, because that is how people arrive. Over-the-counter products account for the larger share of the European e-pharmacy market, and the EU-4 markets plus the UK make up most of that, so this is not a fringe channel.
So what sits on the other side of that search box? Usually a listing assembled from the summary of product characteristics and the patient information leaflet. Those documents are precise, approved and necessary, but they are written in the language of the regulator rather than the language of the shopper. A product indicated for the symptomatic relief of nasal congestion is competing for somebody who typed "blocked nose can't sleep".
The pharmacist translated the symptom into a product. Online, your product page has to do that work.
What are you actually allowed to say?
There are two sets of rules here, and which one applies depends on whether you are selling a licensed medicine or a food supplement.
For licensed medicines, advertising to the public is governed at EU level by Directive 2001/83/EC. Only non-prescription products may be advertised to the public at all, and everything said about them has to stay consistent with the marketing authorisation. In the UK, the MHRA Blue Guide and the CAP Code apply on top of that.
Food supplements sit under a different regime. Regulation (EC) No 1924/2006 limits brands to nutrition and health claims that have been authorised, and a large number of botanical claims remain unresolved, which in practice makes them unusable.
Teams working across both portfolios often apply the medicines rules to everything, which is easier to administer but leaves supplement listings thinner than they need to be.
Where does the real content opportunity sit?
None of those rules stop a listing being found. They govern what you may claim, not how a product is described, categorised or attributed.
Active ingredient. Dosage format. Age suitability. Pack size. Flavour. Drowsy or non-drowsy. Suitable in pregnancy or not. These are facts rather than claims, and they are what shoppers search and filter on.
In practice the rules get read as "we cannot say much about this product online", so the listing ends up thin. Much of the content that drives discovery in this category is factual, permitted, and missing.
How do retailer filters decide what gets found?
Search ranking is a matter of degree. Filters are not. If a retailer offers a filter for non-drowsy antihistamines and your product has no value in that attribute field, it does not rank low in the filtered results. It is absent from them.
It is worth looking for that failure first, because nothing in standard reporting points at it. Sales look soft in a market, the listing looks complete, and the product has quietly dropped out of the two or three filtered views where the category's demand actually sits.
Attribute requirements vary a lot between retailers, too. A value that a pure-play online pharmacy insists on may be optional at a drugstore chain and absent from a marketplace listing altogether. Content Optimizer brings brand targets, category benchmarks and retailer field requirements together, so you can see what a complete listing looks like for each product at each retailer rather than in the abstract.
Ranking is a matter of degree. A missing attribute is a matter of presence or absence.
Where does prevention change the picture?
Vitamins, minerals and supplements continue to outgrow the wider self-care category, and prevention rather than treatment is driving it. Euromonitor research found that 43% of consumers globally take supplements at least weekly, and that a healthspan claim appeared on half of all new supplement products launched over a recent twelve-month period.
That second figure is the interesting one. When half the category is making the same kind of claim, the claim stops doing any work. What is left is what a shopper can compare directly: form, dose, ingredient source, certification, pack size, price per unit, and the reviews of people who have already taken it. Nearly all of that is listing content, and nearly all of it is permitted without restriction.
Competitive benchmarking shows how your listings compare against the category on the signals that are deciding these purchases, and where a competitor has filled in something you have left blank.
What this means for your digital shelf strategy
The rules on what you can claim are not going to change, and they only cover claims. They do not explain a listing with no dosage format, no age suitability and no active ingredient in a searchable field, and they do not explain a product missing from a filter that a large share of the category's demand runs through.
Doing this across markets and retailers depends on accurate, current data. The eStore platform delivers 99.7% data accuracy across more than 3,000 retailer websites in over 70 markets, so you can see where attributes are missing, where products drop out of filtered results, and where a shopper searching a symptom is finding somebody else.
For the full picture on regulatory complexity, content accuracy and multi-market compliance in this category, read the complete guide to digital shelf analytics for pharmaceutical and healthcare brands.
Key Takeaways
- Brand-led search reaches shoppers you have already won. A large share of the remaining demand arrives as symptom or ingredient searches, and OTC listings are usually built from regulatory documents written in a different language.
- Licensed medicines and food supplements sit under different rulebooks, and teams working across both tend to apply the stricter one everywhere.
- Those rules govern claims. They do not restrict factual attributes such as format, dose, age suitability or ingredient naming, which is what shoppers filter on.
- A missing attribute value removes a product from a filtered result set entirely rather than lowering its position, and that rarely shows up in standard reporting.
- Prevention is driving supplement growth, with 43% of consumers taking supplements at least weekly and healthspan claims appearing on half of new launches, so comparable listing content matters more than claim language. The eStore platform provides 99.7% data accuracy across more than 3,000 retailer websites.
Frequently Asked Questions
Why does symptom-led search matter if shoppers already know our brand?
Because brand searches largely reach people who have already chosen you. Symptom and ingredient searches are where undecided shoppers arrive, and there the retailer's search engine decides which products answer the question, using whatever is on the product page.
Do the rules differ between OTC medicines and food supplements?
Yes. Advertising of licensed medicines to the public is governed by Directive 2001/83/EC at EU level, with the MHRA Blue Guide and CAP Code applying in the UK, and all content must stay consistent with the marketing authorisation. Food supplements fall under Regulation (EC) No 1924/2006, which limits brands to authorised nutrition and health claims.
Do advertising rules stop OTC brands from optimising their listings?
They restrict claims rather than description. Factual attributes such as dosage format, active ingredient, age suitability and pack size are not claims, and they are usually where listings are incomplete.
What is the risk of a missing product attribute?
Filters are binary. If a retailer offers a filter your product has no value for, the product is absent from those results rather than ranked lower. Because the listing still looks complete, this is easy to miss in reporting and can account for a persistent gap in a market.
Turn Discovery Into Commercial Advantage
If you lead ecommerce or category for a consumer health or pharmaceutical brand and want to know where your products appear in symptom-led search across European retailers, we would welcome the chance to walk through how it works. Speak to our team for a detailed look at content and attribute monitoring across your markets.
References and Further Reading
- AESGP - European self-care industry association, market and regulatory analysis
- IQVIA Consumer Health - European OTC and self-care market trends
- EU Register of nutrition and health claims - authorised claims for foods and food supplements
- MHRA Blue Guide - UK guidance on advertising and promoting medicines
